Диссертация (1141195), страница 21
Текст из файла (страница 21)
2012 Nov 16.186. Lam FC, Liu R, Lu P, Shapiro AB, Renoir JM, Sharom FJ, Reiner PB.betaAmyloid efflux mediated by p-glycoprotein. J Neurochem. 2001 Feb;76(4):1121-8.187. Lamb RE, Bradford MJ. Controlling hypertension to reduce the risk ofstroke.ProgCardiovascNurs.2002;17:186–191.doi:10.1111/j.0889-7204.2002.01543.x. ).188.
Larsen UL, Hyldahl Olesen L, Guldborg Nyvold C, Eriksen J, Jakobsen P,Østergaard M, Autrup H, Andersen V.. Human intestinal P-glycoprotein activityestimated by the model substrate digoxin. Scand J Clin Lab Invest. 2007;67(2):12334.189. Lee S.S., Kim S.Y., Kim W.Y., Thi-Le H., Yoon Y.R., Yea S.S., Shin J.G.MDR1 genetic polymorphisms and comparison of MDR1 haplotype profiles inKorean and Vietnamese populations.// Ther. Drug. Monit. 2005.
Vol. 27(4). P. 531535.190. Leslie EM, Deeley RG, Cole SP. Multidrug resistance proteins: role of Pglycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol ApplPharmacol. 2005 May 1;204(3):216-37.147191. Letrent SP, Polli JW, Humphreys JE, Pollack GM, Brouwer KR, Brouwer KLP-glycoprotein-mediated transport of morphine in brain capillary endothelial cells.Biochem Pharmacol. 1999192.
Li D., Zhang G.L., Lou Y.Q., Li Q., Wang X., Bu X.Y. Geneticpolymorphisms in MDR1 and CYP3A5 and MDR1 haplotype in mainland ChineseHan, Uygur and Kazakh ethnic groups.// J Clin Pharm Ther. 2007. Vol. 32(1). P. 8995.193. Li WW, Wallhagen MI, Froelicher ES. Hypertension control, predictors formedication adherence and gender differences in older Chinese immigrants. J AdvNurs. 2008;61:326–335. doi: 10.1111/j.1365-2648.2007.04537194. Li Y., Wang Y., Sun J., Li Y., Yang L. Distribution of the functional MDR1C3435T polymorphism in the Han population of China.// Swiss Med. Wkly.
2006.Vol. 136(23-24). P. 377-382.195. Liu B, Qu L, Tao H.Cyclo-oxygenase 2 up-regulates the effect of multidrugresistance.Cell Biol Int. 2009 Dec 16;34(1):21-5.196. LiuH,LiuW,LiaoY,ChengL,LiuQ,RenX,ShiL,TuX,WangQ,GuoAY.CADgene: a comprehensive database for coronary artery disease genes. NucleicAcids Res. 2011 Jan;39.197. Luker GD, Dahlheimer JL, Ostlund RE Jr, Piwnica-Worms D.
Decreasedhepatic accumulation and enhanced esterification of cholesterol in mice deficient inmdr1a and mdr1b P-glycoproteins. J Lipid Res. 2001 Sep;42(9):1389-94.198. MacFarland A, Abramovich DR, Ewen SW, Pearson CK. Stage-specificdistribution of P-glycoprotein in first-trimester and full-term human placenta.Histochem J.
1994 May;26(5):417-23.199. MacKenzie SM, Freel EM, Fraser R, Davies E. A lifetime of aldosteroneexcess: long-term consequences of altered regulation of aldosterone production forcardiovascular function. Endocr Rev. 2008 Apr;29(2):133-54.148200. Magiakou MA, Smyrnaki P, Chrousos GP. Hypertension in Cushing ̓ssyndrome. Best Pract Res Clin Endocrinol Metab. 2006 Sep; 20(3):467-82.201. Maier P, Fleckenstein K, Li L, Laufs S, Zeller WJ, Baum C, Fruehauf S,Herskind C, Wenz F.
Overexpression of MDR1 using a retroviral vectordifferentially regulates genes involved in detoxification and apoptosis and confersradioprotection. Radiat Res. 2006 Sep;166(3):463-73137.202. Marchi N, Hallene KL, Kight KM, Cucullo L, Moddel G, Bingaman W, DiniG, Vezzani A, Janigro D.
Significance of MDR1 and multiple drug resistance inrefractory human epileptic brain. BMC Med. 2004 Oct 9;2:37.203. Markova S, Nakamura T, Sakaeda T, Makimoto H, Uchiyama H, OkamuraN, Okumura K. Genotype-dependent down-regulation of gene expression andfunction of MDR1 in human peripheral blood mononuclear cells under acuteinflammation. Drug Metab Pharmacokinet. 2006 Jun;21(3):194-200.204. Marzocchetti A, Schwarz J, Di Giambenedetto S, Colafigli M, Bracciale L,Fabbiani M, Fantoni M, Trecarichi E, Cauda R, De Luca A. The effect ofpolymorphisms in candidate genes on the long-term risk of lipodystrophy anddyslipidemia in HIV-infected white patients starting antiretroviral therapy.
AIDSRes Hum Retroviruses. 2011 Dec;27(12):1299-309. doi: 10.1089/aid.2010.0172.205. Masunaga Y, Noto T, Suzuki K, Takahashi K, Shimizu Y, Morokata T.Expression profiles of cytokines and chemokines in murine MDR1a-/- colitis. JInflamm Res.2007 Nov;56(11):439-46.206. Mealey K.L. Therapeutic implications of the MDR1 gene.// J. Vet. Pharmacol.Therap. 2004. Vol. 27. P. 257-264.207. MechetnerEglycoproteinmediatedBandRoninsonmultidrugIB.Efficientresistancewithinhibitionaantibody.ProcNatlAcadSci U S A. 1992 July 1; 89(13): 5824–5828ofP-monoclonal149208. Mega J.L., Close S.L., Wiviott S.D., Shen L., Hockett R.D., BrandtJ.T., Walker J.R., Antman E.M., Macias W., Braunwald E., SabatineM.S. Cytochrome p-450 polymorphisms and response to clopidogrel.
N Engl JMed. 2009;360:354-362.209. Meijer OC, Karssen AM, de Kloet ER. Cell- and tIssue-specific effects ofcorticosteroids in relation to glucocorticoid resistance: examples from the brain. JEndocrinol. 2003 Jul;178(1):13-8210. Meisel P., Giebel J., Kunert-Keil C„ Dazert P., Kroemer H.K., Kocher T.MDR1 gene polymorphisms and risk of gingival hyperplasia induced by calciumantagonists.// Clin. Pharmacol. Ther. 2006. Vol. 79(1).
P. 62-71.211. Meissner K, Sperker B, Karsten C, Meyer Zu Schwabedissen H, Seeland U,Böhm M, Bien S, Dazert P, Kunert-Keil C, Vogelgesang S, Warzok R, SiegmundW, Cascorbi I, Wendt M, Kroemer HK. Expression and localization of Pglycoprotein in human heart: effects of cardiomyopathy. J Histochem Cytochem.2002 Oct;50(10):1351-6212. Meredith PA, Elliott HL. Clinical pharmacokinetics of amlodipine.
ClinPharmacokinet. 1992;22:22–31.213. Metherall JE, Li H, Waugh K. Role of multidrug resistance P-glycoproteinsin cholesterol biosynthesis. J Biol Chem. 1996 Feb 2;271(5):2634-40.214. Miller DS, Bauer B, Hartz AM. Modulation of P-glycoprotein at the bloodbrain barrier: opportunities to improve central nervous system pharmacotherapy.Pharmacol Rev. 2008 Jun;60(2):196-209.215. Miller DS.Xenobiotic export pumps, endothelin signaling, and tubularnephrotoxicants--a2002;16(3):121-7.caseofmolecularhijacking.JBiochemMolToxicol.150216. Miura M, Satoh S, Inoue K, Saito M, Habuchi T, Suzuki T. Telmisartanpharmacokinetics in Japanese renal transplant recipients. Clin Chim Acta.
2009Jan;399(1-2):83-7. Epub 2008 Sep 22.217. Morgado M, Rolo S, Macedo AF, et al. Predictors of uncontrolledhypertension and antihypertensive medication nonadherence. J Cardiovasc DisRes. 2010;1:196–202. doi: 10.4103/0975-3583.74218. Morita N., Yasumori Т., Nakayama K. Human MDR1 polymorphism:G2677T/A and C3435T have no effect on MDR1 transport activities.// Biochem.Pharmacol. 2003. Vol. 65(11). P. 1843-1852.219. Moriya Y, Nakamura T, Horinouchi M, Sakaeda T, Tamura T, Aoyama N,Shirakawa T, Gotoh A, Fujimoto S, Matsuo M, Kasuga M, Okumura K. Effects ofpolymorphisms of MDR1, MRP1, and MRP2 genes on their mRNA expressionlevels in duodenal enterocytes of healthy Japanese subjects.
Biol Pharm Bull. 2002Oct;25(10):1356-9.220. Mrozikiewicz PM, Seremak-Mrozikiewicz A, Semczuk A, Landt O,Breborowicz GH, Drews K. The significance of C3435T point mutation of theMDR1 gene in endometrial cancer. Int J Gynecol Cancer. 2007 May- Jun;17(3):72831. Epub 2007 Feb 9.221.
Mughal W, Kirshenbaum LA. Cell death signalling mechanisms in heartfailure. Exp Clin Cardiol. 2011 Winter;16(4):102-8.222. Munteanu E, Verdier M, Grandjean-Forestier F, Stenger C, Jayat-Vignoles C,Huet S, Robert J, Ratinaud MH. Mitochondrial localization and activity of Pglycoprotein in doxorubicin-resistant K562 cells. Biochem Pharmacol.
2006 Apr14;71(8):1162-74. Epub 2006 Feb 24.223. Mutoh K, Mitsuhashi J, Kimura Y, Tsukahara S, Ishikawa E, Sai K, OzawaS, Sawada J, Ueda K, Katayama K, Sugimoto Y. A T3587G germ-line mutation of151the MDR1 gene encodes a nonfunctional P-glycoprotein. Mol Cancer Ther. 2006Apr;5(4):877-84.224. Nakamura T, Okamura N, Yagi M, Omatsu H, Yamamori M, Kuwahara A,Nishiguchi K, Horinouchi M, Okumura K, Sakaeda T. Effects of ABCB1 3435C>Tgenotype on serum levels of cortisol and aldosterone in women with normalmenstrual cycles.
Genet Mol Res. 2009 Apr 7;8(2):397-403.225. Nakamura T, Sakaeda T, Horinouchi M, Tamura T, Aoyama N, Shirakawa T,Matsuo M, Kasuga M, Okumura K. Effect of the mutation (C3435T) at exon 26 ofthe MDR1 gene on expression level of MDR1 messenger ribonucleic acid induodenal enterocytes of healthy Japanese subjects. Clin Pharmacol Ther. 2002Apr;71(4):297-303.226. Nizar M Mhaidat, Osama Y Alshogran, Omar F Khabour, Karem H Alzoubi,Ismail I Matalka, William J Haddadin, Ibraheem O Mahasneh, and Ahmad NAldaher. Multi-drug resistance 1 genetic polymorphism and prediction ofchemotherapy response in Hodgkin's Lymphoma.
J Exp Clin Cancer Res. 2011;30(1): 68227. Nobili S, Landini I, Mazzei T, Mini E.Overcoming tumor multidrug resistanceusing drugs able to evade P-glycoprotein or to exploit its expression.MedResRev.2011 Mar 3. doi: 10.1002/med.20239.Nov;36(4):229-40. 228. Nwaozuzu OM, Sellers LA, Barrand MA. Signalling pathways influencingbasal and H(2)O(2)-induced P-glycoprotein expression in endothelial cells derivedfrom the blood-brain barrier J Neurochem.2003 Nov;87(4):1043-51..229. Ogura J, Kobayashi M, Itagaki S, Hirano T, Iseki K.Alteration of Mrp2 andP-gp expression, including expression in remote organs, after intestinal ischemiareperfusion.LifeSci. 2008 Jun 20;82(25-26):1242-8.152230. Opie LH. Calcium channel antagonists.
Part IV: Side effects andcontraindicationsdruginteractionsandcombinations. CardiovascDrugsTher. 1988;2:177–189.231. Ostrovsky O., Nagler A., Korostishevsky M., Gazit E., and Galski H.Genotype and Allele Frequencies of C3435T Polymorphism of the MDR1 Gene inVarious Jewish Populations of Israel.// Ther Drug Monit.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
